Resources for video
When should RhD genotyping be performed for pregnant D negative women?
When should RhD genotyping be performed for pregnant D negative women? presentation by Dr. Nancy Robitaille
May 25, 2022
Second and third trimester FMH testing and anti-D prophylaxis: Review of routine administration and special situations
Second and third trimester FMH testing and anti-D prophylaxis Review of routine administration and special situations presentation by Dr. Nadine Shehata
May 25, 2022
Prenatal Monitoring Strategies for Lower-risk RBC Alloantibodies
Prenatal Monitoring Strategies for Lower-risk RBC Alloantibodies presentation by Dr. Matthew Yan
May 25, 2022
The group and screen at 28 weeks
The group and screen at 28 weeks presentation by Dr. Jon Barrett
May 25, 2022
The group and screen at 28 weeks
The group and screen at 28 weeks presentation by Dr. Jon Barrett
May 25, 2022
The triage group and screen
The triage group and screen presentation by Jeannie Callum
Dir. of Transfusion Medicine Kingston Health Sciences Centre Queen’s University
May 25, 2022
Fetal maternal hemorrhage testing: the why, how & when
Fetal maternal hemorrhage testing: the why, how & when presentation by Heather VanderMeulen, MD, MSc, FRCPC
Transfusion Medicine Fellow Canadian Blood Services
May 25, 2022
2022 CBS/ORBCoN Technical Dry Workshop
TM Alphabet Soup ABO-RHD-MHP, Dr. Waseem Anani, April 7, 2022
Ontario MHP: Guidance for small/remote hospitals
Dr. Jacob Pendergrast discusses the challenges of MHPs in smaller, more remote hospitals and provides guidance on appropriate modifications to the Ontario massive hemorrhage protocol. March 10, 2022